$0.100000
-0.07-40.55%
Pre-Market: Feb 14, 8:34 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Scopus BioPharma in recent months.
Browse guidance and forecast on all stocks.